{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:43:54Z","timestamp":1790343834523,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012172","name":"Breast Cancer Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012172","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Breast Cancer Foundation and the Queen Elizabeth II Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.yexmp.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T12:18:33Z","timestamp":1547727513000},"page":"10-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells"],"prefix":"10.1016","volume":"107","author":[{"given":"Anna L.","family":"Greenshields","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasundara","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2019.01.006_bb0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/jnci\/djn233","article-title":"Residual risk of breast cancer recurrence 5 years after adjuvant therapy","volume":"100","author":"Brewster","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.434","article-title":"Artesunate induces necrotic cell death in schwannoma cells","volume":"5","author":"Button","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171357","article-title":"Combined drug therapeutic strategies for the effective treatment of triple negative breast cancer","volume":"38","author":"Chalakur-Ramireddy","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0020","article-title":"Ionizing radiation potentiates dihydroartemisinin-induced apoptosis of A549 cells via a caspase-8-dependent pathway","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1439-0264.2002.00398.x","article-title":"Morphological and biochemical aspects of apoptosis, oncosis and necrosis","volume":"31","author":"Cruchten","year":"2002","journal-title":"Anat. Histol. Embryol."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0030","first-page":"2929","article-title":"Breast cancer intrinsic subtype classification, clinical use and future trends","volume":"5","author":"Dai","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0035","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","article-title":"Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo","volume":"65","author":"Du","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1756-9966-30-91","article-title":"Platinum resistance in breast and ovarian cancer cell lines","volume":"30","author":"Eckstein","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0045","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"Efferth","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.breast.2018.03.006","article-title":"HER2-positive breast cancer: current and new therapeutic strategies","volume":"39","author":"Escriva-de-Romani","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10911-016-9359-2","article-title":"Generation of multicellular breat cancer tumor spheroids: comparison of different protocols","volume":"21","author":"Froehlich","year":"2016","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mc.22474","article-title":"Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate","volume":"56","author":"Greenshields","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0065","first-page":"1","article-title":"Free radicals and other reactive species in disease","volume":"2001","author":"Halliwell","year":"2001","journal-title":"Encycl. Life Sci."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0070","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","article-title":"Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production","volume":"286","author":"Hamacher-Brady","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: Pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0080","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action","volume":"14","author":"Hou","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0085","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/CAD.0b013e328350e8ac","article-title":"Artesunate induces G0\/G1 cell cycle arrest and iron-mediated mitochondrial apoptosis in A431 human epidermoid carcinoma cells","volume":"23","author":"Jiang","year":"2012","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbrc.2012.02.027","article-title":"Cycling hypoxia up-regulates thioredoxin levels in human MDA-MB-231 breast cancer cells","volume":"419","author":"Karlenius","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.gco.0000192996.20040.24","article-title":"Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients","volume":"18","author":"Kayl","year":"2006","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0100","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2174\/0929867033456710","article-title":"An over four millennium story behind qinghaosu (artemisinin)-a fantastic antimalarial drug from a traditional Chinese herb","volume":"10","author":"Li","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0105","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/ijc.22804","article-title":"Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/\u03b2-catenin pathway","volume":"121","author":"Li","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0110","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/ijc.25707","article-title":"The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies","volume":"128","author":"Liu","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"\u03b3H2AX: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"Mah","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3892\/ijmm.2012.1176","article-title":"Involvement of the mitochondrial pathway and Bim\/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro","volume":"31","author":"Mao","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0125","first-page":"1339","article-title":"Treatment of breast cancer","volume":"81","author":"Maughan","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0130","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ctrv.2012.02.011","article-title":"Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies","volume":"38","author":"Murray","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5115\/acb.2012.45.2.73","article-title":"From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers","volume":"45","author":"Nurwidya","year":"2012","journal-title":"Anat. Cell Biol."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0140","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/jps.20874","article-title":"Oxidative stress and apoptosis\u202f: impact on cancer therapy","volume":"96","author":"Ozben","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0145","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJMct0709050","article-title":"Artesunate for the treatment of severe falciparum malaria","volume":"358","author":"Rosenthal","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0150","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/srep02513","article-title":"A plausible mechanism for the antimalarial activity of artemisinin: a computational approach","volume":"3","author":"Shandilya","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0155","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12032-016-0814-0","article-title":"Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours","volume":"33","author":"Stepie\u0144","year":"2016","journal-title":"Med. Oncol."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0165","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0170","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","article-title":"Free radicals, metals and antioxidants in oxidative stress-induced cancer","volume":"160","author":"Valko","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2004.07.006","article-title":"Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity","volume":"23","author":"Vellonen","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0190","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/carcin\/bgs232","article-title":"The rebel angel: mutant p53 as the driving oncogene in breast cancer","volume":"33","author":"Walerych","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexmp.2019.01.006_bb0195","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bcp.2012.02.002","article-title":"Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo","volume":"83","author":"Zhang","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexmp.2019.01.006_bb0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00280-009-1129-z","article-title":"Dihydroartesunateemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro","volume":"66","author":"Zhou","year":"2010","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480018302776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480018302776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:46:49Z","timestamp":1757990809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480018302776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":40,"alternative-id":["S0014480018302776"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.01.006","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}